IP Library › Granted Patent US 12,409,321
Granted Patent B2
US 12,409,321 · App. 17/575,766 · Granted Sep 9, 2025

Method for disc therapy

Inventors: Yossi Gross (Moshav Mazor, IL); Zev Sohn (Ginot Shomron, IL)
Assignee: Discure Technologies Ltd.
A61N1/205A61N1/0551A61N1/306A61N1/325A61N1/326A61N1/327A61N1/3606
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,409,321
App. No.
17/575,766
Granted
Sep 9, 2025
Kind
B2
Abstract

A method is provided that includes providing an electrode, which includes a wire that has a wire diameter of between 75 and 125 microns. The wire includes a non-electrically-insulated current-application longitudinal segment, which, in the absence of any applied forces, is coiled and has (i) an outer coil diameter of between 3 and 7 times the wire diameter, and (ii) an entire longitudinal length of between 5 and 35 mm. The wire further includes an electrically-insulated lead longitudinal segment, which has an entire longitudinal length of at least 10 mm, in the absence of any applied forces. At least a portion of the electrode is implanted in a body of a subject. Other embodiments are also described.

Claims (30)

1. A method comprising:

providing an electrode, which includes a wire that (a) has a wire diameter of between 75 and 125 microns and (b) includes:

(1) a non-electrically-insulated current-application longitudinal segment, which, in the absence of any applied forces, is coiled and has (i) an outer coil diameter of between 3 and 7 times the wire diameter, and (ii) an entire longitudinal length of between 5 and 35 mm, and

(2) an electrically-insulated lead longitudinal segment, which has an entire longitudinal length of at least 10 mm, in the absence of any applied forces; and

implanting at least a portion of the electrode in a body of a subject.

2. The method according to claim 1 , wherein the current-application longitudinal segment has an outer coil diameter of between 3 and 7 times the wire diameter, in the absence of any applied forces.

3. The method according to claim 2 , wherein the outer coil diameter of the current-application longitudinal segment is between 4 and 6 times the wire diameter, in the absence of any applied forces.

4. The method according to claim 1 , wherein the current-application longitudinal segment has an outer coil diameter of between 400 and 600 microns, in the absence of any applied forces.

5. The method according to claim 1 , wherein the current-application longitudinal segment has a mean pitch of between 1.1 and 2 times the wire diameter.

6. The method according to claim 5 , wherein the mean pitch of the current-application longitudinal segment is between 1.2 and 1.8 times the wire diameter, in the absence of any applied forces.

7. The method according to claim 1 , wherein the wire diameter is between 90 and 110 microns.

8. The method according to claim 1 , wherein the entire longitudinal length of the current-application longitudinal segment is between 10 and 25 mm, in the absence of any applied forces.

9. The method according to claim 1 , wherein the current-application longitudinal segment extends to a distal end of the wire.

10. The method according to claim 1 , wherein the lead longitudinal segment is coiled, in the absence of any applied forces.

11. The method according to claim 10 , wherein the lead longitudinal segment has a mean pitch that is greater than the mean pitch of the current-application longitudinal segment, in the absence of any applied forces.

12. The method according to claim 11 , wherein the mean pitch of the lead longitudinal segment is at least 125% of the mean pitch of the current-application longitudinal segment, in the absence of any applied forces.

13. The method according to claim 10 , wherein the lead longitudinal segment has a mean pitch of between 2 and 3 times the wire diameter, in the absence of any applied forces.

14. The method according to claim 10 , wherein the lead longitudinal segment has an outer coil diameter that equals between 90% and 110% of an outer coil diameter of the current-application longitudinal segment, in the absence of any applied forces.

15. The method according to claim 10 , wherein the lead longitudinal segment has an outer coil diameter of between 3 and 7 times the wire diameter, in the absence of any applied forces.

16. The method according to claim 1 , further comprising activating control circuitry, which is electrically coupled to the electrode, to drive the electrode to apply a current.

17. The method according to claim 1 , wherein the non-electrically-insulated current-application longitudinal segment, in the absence of any applied forces, is shaped so as to define an empty inner channel therethrough.

18. The method according to claim 1 , wherein implanting the at least a portion of the electrode includes implanting the at least a portion of the electrode such that:

the current-application longitudinal segment is disposed at least partially in an intervertebral disc of the subject, and

at least a portion of the lead longitudinal segment is disposed in the body of the subject outside the intervertebral disc.

19. The method according to claim 18 , wherein implanting the at least a portion of the electrode includes implanting the at least a portion of the electrode such that the current-application longitudinal segment is disposed entirely in a nucleus pulposus of the intervertebral disc.

20. The method according to claim 18 ,

wherein the wire further includes an intermediate longitudinal segment, which (a) is longitudinally between the current-application longitudinal segment and the lead longitudinal segment, (b) has an entire longitudinal length of between 1 and 6 mm, in the absence of any applied forces, and (c) in the absence of any applied forces, either (i) is coiled, and has a mean pitch greater than an outer coil diameter of the current-application longitudinal segment or (ii) is not coiled, and

wherein implanting the at least a portion of the electrode includes implanting the at least a portion of the electrode such that the intermediate longitudinal segment is disposed at least in part in an annulus fibrosus of the intervertebral disc.

21. The method according to claim 20 , wherein the intermediate longitudinal segment is electrically insulated along at least a longitudinal portion of the intermediate longitudinal segment.

22. The method according to claim 20 , wherein, in the absence of any applied forces, the intermediate longitudinal segment is coiled, and has the mean pitch greater than the outer coil diameter of the current-application longitudinal segment.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2022
From: RAINBOW MEDICAL LTD.
To: DISCURE TECHNOLOGIES LTD.
Reel/Frame 059115/0357 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2022
From: GROSS, YOSSI; SOHN, ZEV
To: RAINBOW MEDICAL LTD.
Reel/Frame 059071/0343 →
Continuity (4)
Division 17386937 · Jul 28, 2021
Continuation 16332606
Continuation 15263910 · Sep 13, 2016
Related Publication 20220134093A1 · May 5, 2022
References Cited (173)
US 2959410A · Fullam et al. · 1960 [cited by applicant]
US 4044774A · Corbin et al. · 1977 [cited by applicant]
US 4503863A · Katims · 1985 [cited by applicant]
US 5088977A · Sibalis · 1992 [cited by applicant]
US 5121754A · Mullett · 1992 [cited by applicant]
US 5433739A · Sluijter et al. · 1995 [cited by applicant]
US 5529574A · Frackelton · 1996 [cited by applicant]
US 5587297A · Jacobson et al. · 1996 [cited by applicant]
US 5792100A · Shantha · 1998 [cited by applicant]
US 5911223A · Weaver et al. · 1999 [cited by applicant]
US 5919163A · Glickman · 1999 [cited by applicant]
US 5938690A · Law et al. · 1999 [cited by applicant]
US 6041252A · Walker et al. · 2000 [cited by applicant]
US 6146380A · Racz et al. · 2000 [cited by applicant]
US 6161047A · King et al. · 2000 [cited by applicant]
US 6360750B1 · Gerber et al. · 2002 [cited by applicant]
US 6416510B1 · Altman · 2002 [cited by examiner]
US 6506408B1 · Palasis · 2003 [cited by applicant]
US 6567702B1 · Nekhendzy et al. · 2003 [cited by applicant]
US 6591138B1 · Fischell et al. · 2003 [cited by applicant]
US 6602248B1 · Sharps et al. · 2003 [cited by applicant]
US 6620155B2 · Underwood et al. · 2003 [cited by applicant]
US 6907295B2 · Gross et al. · 2005 [cited by applicant]
US 6941172B2 · Nachum · 2005 [cited by applicant]
US 6997941B2 · Sharkey et al. · 2006 [cited by applicant]
US 7120489B2 · Shalev et al. · 2006 [cited by applicant]
US 7217351B2 · Krumme · 2007 [cited by applicant]
US 7223227B2 · Pflueger · 2007 [cited by applicant]
US 7270659B2 · Ricart et al. · 2007 [cited by applicant]
US 7398121B2 · Matsumura et al. · 2008 [cited by applicant]
US 7509171B2 · DiMauro · 2009 [cited by applicant]
US 7640062B2 · Shalev · 2009 [cited by applicant]
US 7831306B2 · Finch et al. · 2010 [cited by applicant]
US 7860569B2 · Solberg et al. · 2010 [cited by applicant]
US 8190248B2 · Besio et al. · 2012 [cited by applicant]
US 8457761B2 · Wariar · 2013 [cited by applicant]
US 8577469B2 · Gross · 2013 [cited by applicant]
US 8676348B2 · Gross · 2014 [cited by applicant]
US 9616221B2 · Gross · 2017 [cited by applicant]
US 9724513B2 · Lane et al. · 2017 [cited by applicant]
US 9770591B2 · Gross et al. · 2017 [cited by applicant]
US 9950156B2 · Gross et al. · 2018 [cited by applicant]
US 20020151948A1 · King et al. · 2002 [cited by applicant]
US 20020183683A1 · Lerner · 2002 [cited by applicant]
US 20030130707A1 · Gan et al. · 2003 [cited by applicant]
US 20030158589A1 · Katsnelson · 2003 [cited by applicant]
US 20030216792A1 · Levin et al. · 2003 [cited by applicant]
US 20030225331A1 · Diederich et al. · 2003 [cited by applicant]
US 20040002746A1 · Ryan et al. · 2004 [cited by applicant]
US 20040019381A1 · Pflueger · 2004 [cited by applicant]
US 20040049180A1 · Sharps et al. · 2004 [cited by applicant]
US 20040116977A1 · Finch et al. · 2004 [cited by applicant]
US 20040210209A1 · Yeung et al. · 2004 [cited by applicant]
US 20040225363A1 · Richelsoph · 2004 [cited by applicant]
US 20040253304A1 · Gross et al. · 2004 [cited by applicant]
US 20040267240A1 · Gross et al. · 2004 [cited by applicant]
US 20050010205A1 · Hovda et al. · 2005 [cited by applicant]
US 20050021104A1 · DiLorenzo · 2005 [cited by applicant]
US 20050058701A1 · Gross et al. · 2005 [cited by applicant]
US 20050119650A1 · Sanders et al. · 2005 [cited by applicant]
US 20050159790A1 · Shalev · 2005 [cited by applicant]
US 20050277996A1 · Podhajsky et al. · 2005 [cited by applicant]
US 20060030895A1 · Simon et al. · 2006 [cited by applicant]
US 20060106430A1 · Fowler et al. · 2006 [cited by applicant]
US 20060224223A1 · Podhajsky et al. · 2006 [cited by applicant]
US 20060276844A1 · Alon et al. · 2006 [cited by applicant]
US 20060293723A1 · Whitehurst et al. · 2006 [cited by applicant]
US 20070000784A1 · Paul et al. · 2007 [cited by applicant]
US 20070073402A1 · Vresilovic et al. · 2007 [cited by applicant]
US 20070213700A1 · Davison et al. · 2007 [cited by applicant]
US 20080009927A1 · Vilims · 2008 [cited by applicant]
US 20080063703A1 · Gross et al. · 2008 [cited by applicant]
US 20080119907A1 · Stahmann · 2008 [cited by applicant]
US 20080188837A1 · Belsky et al. · 2008 [cited by applicant]
US 20080260542A1 · Nishikawa et al. · 2008 [cited by applicant]
US 20080275430A1 · Belsky et al. · 2008 [cited by applicant]
US 20090112278A1 · Wingeier et al. · 2009 [cited by applicant]
US 20090125080A1 · Montgomery · 2009 [cited by applicant]
US 20090126813A1 · Yanagisawa et al. · 2009 [cited by applicant]
US 20090131850A1 · Geiger · 2009 [cited by applicant]
US 20090312816A1 · Gross · 2009 [cited by applicant]
US 20100217369A1 · Gross · 2010 [cited by applicant]
US 20100324441A1 · Hargrove et al. · 2010 [cited by applicant]
US 20110046540A1 · Alterman et al. · 2011 [cited by applicant]
US 20110160638A1 · Mauge et al. · 2011 [cited by applicant]
US 20110160797A1 · Makous et al. · 2011 [cited by applicant]
US 20120203307A1 · Schroeppel et al. · 2012 [cited by applicant]
US 20130066392A1 · Simon et al. · 2013 [cited by applicant]
US 20130102952A1 · Gross · 2013 [cited by applicant]
US 20130166006A1 · Williams · 2013 [cited by applicant]
US 20140058189A1 · Stubbeman · 2014 [cited by applicant]
US 20140088672A1 · Bedenbaugh · 2014 [cited by applicant]
US 20140207224A1 · Simon · 2014 [cited by applicant]
US 20140257168A1 · Gill · 2014 [cited by applicant]
US 20140324128A1 · Gross · 2014 [cited by applicant]
US 20150011927A1 · Hua · 2015 [cited by applicant]
US 20150119898A1 · Desalles et al. · 2015 [cited by applicant]
US 20160144164A1 · Sedighiani · 2016 [cited by applicant]
US 20160331970A1 · Lozano · 2016 [cited by applicant]
US 20170007823A1 · Gross · 2017 [cited by applicant]
US 20170120053A1 · Fostick et al. · 2017 [cited by applicant]
US 20170182317A1 · Gross et al. · 2017 [cited by applicant]
US 20180071523A1 · Gross et al. · 2018 [cited by applicant]
WO 9405369 · 1994 [cited by applicant]
WO 0152931 · 2001 [cited by applicant]
WO 0185027 · 2001 [cited by applicant]
WO 2001085094 · 2001 [cited by applicant]
WO 2004066903 · 2004 [cited by applicant]
WO 2005105053 · 2005 [cited by applicant]
WO 2006064502 · 2006 [cited by applicant]
WO 2006064503 · 2006 [cited by applicant]
WO 2006090397 · 2006 [cited by applicant]
WO 2006123346 · 2006 [cited by applicant]
WO 2008007369 · 2008 [cited by applicant]
WO 2008084477 · 2008 [cited by applicant]
WO 2017006327 · 2017 [cited by applicant]
WO 2017072769 · 2017 [cited by applicant]
A Notice of Allowance dated Nov. 22, 2021, which issued during the prosecution of U.S. Appl. No. 17/386,937. [cited by applicant]
A Corrected Notice of Allowability dated Jan. 18, 2022, which issued in U.S. Appl. No. 17/386,937. [cited by applicant]
Karran September E et201 al., 1 “The Amyloid cascade hypothesis for AD,” Nature Reviews Drug Discovery, vol. 10; 698-712,. [cited by applicant]
De La Torre JC, “Vascular Basis of Alzheimer's Pathogensis,” Ann NY Acad Sci. 977:196-215 (Nov. 2002). [cited by applicant]
Weller RO et al., “Perivascular Drainage of Amyloid-b Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease,” Brain Pathology 18 (Apr. 2008) 253-266. [cited by applicant]
Brief PubMed search for metal ions in Alzheimers. [cited by applicant]
An Office Action dated Sep. 27, 2016, which issued during the prosecution of U.S. Appl. No. 14/926,705. [cited by applicant]
An International Search Report and a Written Opinion both dated Aug. 7, 2008, which issued during the prosecution of Applicant's PCT/IL2007/000865. [cited by applicant]
An Office Action dated Mar. 29, 2013, which issued during the prosecution of U.S. Appl. No. 12/373,306. [cited by applicant]
An Office Action dated Oct. 31, 2011, which issued during the prosecution of U.S. Appl. No. 12/373,306. [cited by applicant]
An Office Action dated Oct. 1, 2012, which issued during the prosecution of U.S. Appl. No. 12/373,306. [cited by applicant]
Notice of Allowance dated Jul. 24, 2013, which issued during the prosecution of U.S. Appl. No. 12/373,306. [cited by applicant]
An Office Action dated Apr. 11, 2013, which issued during the prosecution of U.S. Appl. No. 13/663,757. [cited by applicant]
Notice of Allowance dated Oct. 28, 2013, which issued during the prosecution of U.S. Appl. No. 13/663,757. [cited by applicant]
Elixmann IM et al., “In-vitro evaluation of a drainage catheter with integrated bioimpedance electrodes to determine ventricular size,” Biomed Tech 2013; 58 (Suppl. 1) Sep. 2013 (2 pages total). [cited by applicant]
An Office Action dated Aug. 31, 2015, which issued during the prosecution of U.S. Appl. No. 13/872,794. [cited by applicant]
An Applicant Initiated Interview Summary dated Dec. 14, 2015, which issued during the prosecution of U.S. Appl. No. 13/872,794. [cited by applicant]
An Office Action dated Feb. 3, 2016, which issued during the prosecution of U.S. Appl. No. 13/872,794. [cited by applicant]
Notice of Allowance dated Dec. 9, 2016, which issued during the prosecution of U.S. Appl. No. 14/794,739. [cited by applicant]
An Applicant Initiated Interview Summary dated Feb. 25, 2016, which issued during the prosecution of U.S. Appl. No. 13/872,794. [cited by applicant]
An Office Action dated Jun. 15. 2016, which issued during the prosecution of U.S. Appl. No. 13/872,794. [cited by applicant]
An International Search Report and a Written Opinion both dated Oct. 20, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050728. [cited by applicant]
An International Search Report and a Written Opinion both dated Sep. 2, 2008, which issued during the prosecution of Applicant's PCT/IL2008/000038. [cited by applicant]
An International Search Report and a Written Opinion both dated Jan. 26, 2017, which issued during the prosecution of Applicant's PCT/IL2016/051161. [cited by applicant]
An International Preliminary Report on Patentability dated Dec. 22, 2009, which issued during the prosecution of Applicant's PCT/IL2008/000038. [cited by applicant]
An Office Action dated May 26, 2017, which issued during the prosecution of U.S. Appl. No. 15/453,290. [cited by applicant]
An International Preliminary Report on Patentability dated Apr. 7, 2009, which issued during the prosecution of Applicant's PCT/IL2007/000865. [cited by applicant]
Loutzenhiser, “Membrane Potential measurements in renal afferent and efferent arterioles: actions of Angiotensin II”, AJP—Renal Physiol Aug. 1, 1997 vol. 273 No. 2 F307-F314. [cited by applicant]
U.S. Appl. No. 60/830,717, filed Jul. 12, 2006. [cited by applicant]
Dao-Sheng Liu et al., “Activation of Na+ and K+ Pumping Modes of (Na,K)-ATPase by an Oscillating Electric Field,” The Journal of Biological Chemistry, vol. 265. No. 13, May 5, 1990. (pp. 7260-7267). [cited by applicant]
Robert F. Service.. “Electric fields deliver drugs into tumors.” http://news.sciencemaa.ora. Feb. 4, 2015. (5 Pages Total). [cited by applicant]
Vernengo J, “Injectable Bioadhesive Hydrogels for Nucleus Pulposus Replacement and Repair of the Damaged Intervertebral Disc: A Thesis,” Drexel University (Jan. 2007). [cited by applicant]
Urban JPG et al., “The nucleus of the intervertebral disc from development to degeneration,” American Zoologist 40(1): 53-61 (2000). [cited by applicant]
Cheung KMC et al., “Intervertebral disc regeneration by use of autologous mesenchymal stem cells, an experimental model in rabbits,” Abstract from the SRS 2004 Annual Meeting. [cited by applicant]
An Office Action dated Jan. 16, 2015, which issued during the prosecution of U.S. Appl. No. 13/872,794. [cited by applicant]
“Implanting ultrathin electrodes in soft tissue,” https://www.youtube.com/watch?v=FaBYQ68JIM8&spfreload=10, Published on Oct. 10, 2014 (excerpts from video). [cited by applicant]
Iatridis JC et al., “Influence of fixed charge density magnitude and distribution on the intervertebral disc: applications of a poroelastic and chemical electric (PEACE) model,” J Biomech Eng. 125(1):12-24 (Feb. 2003). [cited by applicant]
Freemont TJ et al., “Degeneration of intervertebral discs: current understanding of cellular and molecular events, and implications for novel therapies,” Expert Reviews in Molecular Biology, Mar. 29, 2001 (Cambridge Uni… [cited by applicant]
An Office Action dated Sep. 12, 2011, which issued during the prosecution of U.S. Appl. No. 12/373,306. [cited by applicant]
An Office Action dated Jul. 24, 2017, which issued during the prosecution of U.S. Appl. No. 14/982,187. [cited by applicant]
An International Search Report and a Written Opinion both dated Mar. 10, 2017, which issued during the prosecution of Applicant's PCT/IL2016/051363. [cited by applicant]
An Office Action dated Apr. 25, 2018, which issued during the prosecution of U.S. Appl. No. 15/637,330. [cited by applicant]
“ActivL® Artificial Disc” Patient Information, Aesculap ImplantSystems, LLC, Jun. 2015, pp. 1-49. [cited by applicant]
“Hydropneumatic suspension,” Wikipedia, downloaded May 19, 2019from url https://en.wikipedia.org/wiki/Hydropneumatic_suspension, pp. 1-11. [cited by applicant]
“Charite Artificial Disc Patient Information”, DePuy Spine, Inc., Oct. 2004, pp. 34-41. [cited by applicant]
“ProDisc C Disc Replacement. For single level spinal arthroplasty from C3 to C7. Technique Guide”, Centinel Spine, Sep. 2017, pp. 1-32. [cited by applicant]
“M6-C Artificial Cervical Disc, The Natural Choice for CervicalDisc Replacement”, Orthofix Holdings, Inc., Mar. 2019, pp. 1-6. [cited by applicant]
Gornet, Matthew F. et al., “MAVERICK Total Disc Replacement,” Plastric Surgery Key, https://plasticsurgerykey.com/maverick-total-disc-replacement/, downloaded from url on Dec. 1, 2019, pp. 1-7. [cited by applicant]
“Kineflex Lumbar Disc”, Southern Medical, http://www.southmed.co.za/kineflexlumbar-disc-72, downloaded from url on Dec. 2, 2019, pp. 1-2. [cited by applicant]
Lauweryns, Philippe, “Design and Surgical Technique of the FlexiCore Lumbar Artificial Disc,” Neupsy Key, https://neupsykey.com/design-and-surgicaltechnique-of-the-flexicore-lumbar-artificial-disc/, downloaded from url … [cited by applicant]
Szpalski M et al., “Spine arthroplasty: a historical review,” Eur Spine J, vol. 11, Suppl. 2, 2002, pp. S65-S84. [cited by applicant]
Notice of Allowance dated Dec. 13, 2017, which issued during the prosecution of U.S. Appl. No. 15/263,910. [cited by applicant]
Corrected Notice of Allowability dated Jan. 3, 2018, which issued during the prosecution of U.S. Appl. No. 15/263,910. [cited by applicant]
An Invitation to pay additional fees dated Dec. 12, 2017, which issued during the prosecution of Applicant's PCT/IL2017/051032. [cited by applicant]
An International Search Report and a Written Opinion both dated Feb. 12, 2018, which issued during the prosecution of Applicant's PCT/IL2017/051032. [cited by applicant]
Notice of Allowance dated May 7, 2021, which issued during the prosecution of U.S. Appl. No. 16/332,606. [cited by applicant]